Dicerna Pharmaceuticals
DRNA
#3563
Rank
A$4.75 B
Marketcap
$61.06
Share price
0.00%
Change (1 day)
18,776.54%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -A$0.16 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. In 2020 the company made an earning of -A$0.18 Billion, an increase over its 2019 earnings that were of -A$0.2 Billion.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.16 Billion-9.81%
2020-A$0.18 Billion-11.52%
2019-A$0.2 Billion38.33%
2018-A$0.15 Billion46.14%
2017-A$96.8 Million1.8%
2016-A$95.09 Million-5.58%
2015-A$0.11 Billion32.01%
2014-A$76.28 Million171.79%
2013-A$28.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$66.1 Million-64.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.93 Billion 393.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.09 B-6,001.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.3 Billion 58.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.92 B-12,826.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.47 B-4,076.98%๐Ÿ‡บ๐Ÿ‡ธ USA